Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Chimerix, Inc. (CMRX)

« Back to company index

CMRX Chatter Timeline

Stock Ticker for CMRX

Most Active Tweeters for CMRX

UserTweets
@FlashAlert_me 5
@InsiderAlerts4U 4
@Tickeron 4
@semodough 3
@ChartMill 3

Recent Tweets for CMRX

ChartMill @ChartMill
$CMRX has a poor technical rating and the quality of the setup is also only medium at the moment.… https://t.co/9nzzt6adxu
1:01am
ColoBigM @ColoBigM
@semodough $CMRX - Where are you finding that they exercised the new options? I only see Form 4's for the award of options. TIA...
January 25th 2022, 8:01pm
hesham_monica @hesham_monica
$CMRX Awaiting Buy Signal. Free Trial https://t.co/wUyihfppva https://t.co/WPMzFmMgtb
January 25th 2022, 4:01pm
Gambiste1 @Gambiste1
RT @leeryangames: @disclosetv IVE BEEN LONG $CMRX and $SIGA LETS GOOOOOOOOOO PAYDAY BABY
January 25th 2022, 1:01pm
leeryangames @leeryangames
@disclosetv IVE BEEN LONG $CMRX and $SIGA LETS GOOOOOOOOOO PAYDAY BABY
January 25th 2022, 1:01pm
MarketChmln @MarketChmln
$CMRX option volume was 6X normal on Friday with 3,113 contracts. Call volume was 5% and put volume was 95%. https://t.co/ANS8LyRX58
January 23rd 2022, 10:01pm
userFZ3 @userFZ3
Some good companies to make profit off the fuckery are $SIGA and $CMRX. Though I wouldn’t buy them right now. Let t… https://t.co/pcJVSBGcZP
January 23rd 2022, 2:01am
SweepCastApp @SweepCastApp
SweepCast alerted: $CMRX with Unusual Options Activity Alerted on $5 PUT Expiring: 02-18-2022 worth 137K? |? Learn… https://t.co/6N4wZrKlz1
January 23rd 2022, 12:01am
leeryangames @leeryangames
@disclosetv $CMRX AND $SIGA LONG LETS GOOOO
January 22nd 2022, 3:01am
InsiderAlerts4U @InsiderAlerts4U
$CMRX: New Insider Filing on CHIMERIX INC's Chief Executive Officer MICHAEL A. SHERMAN: https://t.co/JkabG2yaBz
January 21st 2022, 7:01pm
Tickeron @Tickeron
$CMRX's price moved below its 50-day Moving Average on January 12, 2022. View odds for this and other indicators:… https://t.co/GCi0KRQ2D5
January 21st 2022, 1:01pm
InsiderAlerts4U @InsiderAlerts4U
$CMRX: New Insider Filing on CHIMERIX INC's Principal Accounting Officer DAVID JAKEMAN: https://t.co/rZ8hbmGI6Y
January 21st 2022, 12:01pm
InsiderAlerts4U @InsiderAlerts4U
$CMRX: New Insider Filing on CHIMERIX INC's Chief Medical Officer ALLEN S. MELEMED: https://t.co/fBY6IMC9pV
January 21st 2022, 11:01am
InsiderAlerts4U @InsiderAlerts4U
$CMRX: New Insider Filing on CHIMERIX INC's Chief Business Officer and CFO MICHAEL T. ANDRIOLE: https://t.co/79eMiIqscK
January 21st 2022, 7:01am
newsfilterio @newsfilterio
Chimerix to Present at B. Riley Virtual Oncology Conference $CMRX https://t.co/aGAIG4kat3
January 21st 2022, 4:01am
Tickeron @Tickeron
$CMRX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/OoEmFycKsu
January 21st 2022, 1:01am
FlashAlert_me @FlashAlert_me
$CMRX [15s. delayed] filed SEC form 4: Chief Medical Officer Melemed Allen S.: Transacted Derivative Securities on… https://t.co/E22azWQpFe
January 21st 2022, 12:01am
FlashAlert_me @FlashAlert_me
$CMRX [15s. delayed] filed SEC form 4: Principal Accounting Officer Jakeman David: Granted 14,900 of Common Stock… https://t.co/SVnzWzRVzI
January 21st 2022, 12:01am
FlashAlert_me @FlashAlert_me
$CMRX [15s. delayed] filed SEC form 4: Chief Business Officer and CFO Andriole Michael T.: Transacted Derivative S… https://t.co/L7Vk4njVpl
January 20th 2022, 11:01pm
FlashAlert_me @FlashAlert_me
$CMRX [15s. delayed] filed SEC form 4: Chief Executive Officer Sherman Michael A.: Transacted Derivative Securitie… https://t.co/RaoUp2Noro
January 20th 2022, 11:01pm
TradeWithAlerts @TradeWithAlerts
Nice print for $CMRX Size: 112589 Price: 5.58 Amount: $628,246.62 Time: 1600 See more: https://t.co/tHjfNSo0rg Join… https://t.co/3xQtdmvoCi
January 20th 2022, 9:01pm
ShogunTrade @ShogunTrade
$CMRX Bullish pattern forming. Chart by https://t.co/6vnULU2sSf https://t.co/MUN394cXy7
January 20th 2022, 6:01pm
phasefivebot @phasefivebot
$CMRX Chimerix to Present at B. Riley Virtual Oncology Conference https://t.co/NA90xst0wU
January 20th 2022, 1:01pm
StockNewsBot2 @StockNewsBot2
$CMRX Chimerix to Present at B. Riley Virtual Oncology Conference https://t.co/G8MybY8Czk
January 20th 2022, 1:01pm
stock_titan @stock_titan
$CMRX Chimerix to Present at B. Riley Virtual Oncology Conference https://t.co/3zHSaOWgPk
January 20th 2022, 1:01pm
bthefirsttoknow @bthefirsttoknow
First out// $CMRX: Chimerix to Present at B. Riley Virtual Oncology Conference https://t.co/sI182FifZq
January 20th 2022, 1:01pm
AnotherBio @AnotherBio
@BertrandBio @bradloncar look at $CMRX. These guys have a multi-million-dollar payback ahead of them, just by kicki… https://t.co/833brmel5P
January 20th 2022, 12:01pm
NMarmot61 @NMarmot61
RT @semodough: HCW $CMRX believe these data support potential indications for ONC201 outside H3 K27M-mutant diffuse midline glioma. launch…
January 20th 2022, 9:01am
Franca_ole @Franca_ole
It is not a question of if but when $CMRX will break out to the upside! JMHO https://t.co/BP9sAQ8YS6 https://t.co/uyzKWiOAGz
January 19th 2022, 10:01pm
semodough @semodough
@buysidebio Mike Sherman no stranger to making a good deal - stay tuned $CMRX
January 19th 2022, 5:01pm
zbiotech @zbiotech
if only $CMRX would have tweaked some western blots in their pub, they'd be en route to a $SAVA mkt cap...ie >3x current
January 19th 2022, 4:01pm
semodough @semodough
HCW $CMRX believe these data support potential indications for ONC201 outside H3 K27M-mutant diffuse midline glioma… https://t.co/7to6KyqcKn
January 19th 2022, 1:01pm
ShogunTrade @ShogunTrade
$CMRX Awaiting Buy Signal. Chart by https://t.co/6vnULU2sSf https://t.co/JVEoy01YBq
January 19th 2022, 12:01pm
VatqLu @VatqLu
$CMRX Waiting for Buy signal. https://t.co/oivmK9S7CC
January 19th 2022, 12:01pm
StckPro @StckPro
$CMRX NEW ARTICLE : H.C. Wainwright Thinks Chimerix’s Stock is Going to Recover https://t.co/PoIVY1Jl4o Get all the… https://t.co/COt3oiIxm7
January 19th 2022, 11:01am
Briefingcom @Briefingcom
$CMRX: Chimerix announces publication of ONC201 data from Phase 2 study in neuroendocrine tumors https://t.co/DnAUqI2RTC
January 18th 2022, 11:01pm
RJ248842 @RJ248842
$CMRX data were previously disclosed (as company notes).
January 18th 2022, 10:01pm
MarcJacksonLA @MarcJacksonLA
$CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinica… https://t.co/OY1av4vZ3l
January 18th 2022, 10:01pm
rozzieryan @rozzieryan
Should be good for at least -10% $CMRX https://t.co/wStXq97Q8m
January 18th 2022, 10:01pm
hephaistos_ai @hephaistos_ai
RT @GeorgeB14941177: $CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical #…
January 18th 2022, 9:01pm
GeorgeB14941177 @GeorgeB14941177
$CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinica… https://t.co/Fr3eY0Bnam
January 18th 2022, 9:01pm
mehabecapital @mehabecapital
$CMRX @ 5.62 (-6.33%) : Chimerix announces publication of study data for the cancer candidate https://t.co/5qNToAP8yq
January 18th 2022, 9:01pm
sv_capitalhldg @sv_capitalhldg
RT @semodough: $CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer…
January 18th 2022, 9:01pm
newsinthemarket @newsinthemarket
Chimerix publishes ONC201 study data in Clinical Cancer Research journal $CMRX
January 18th 2022, 9:01pm
PennyStockNews5 @PennyStockNews5
$CMRX ? Sentiments: title -0.2023 | summary -0.3182 Aft-Price: 6 | Bid: 5.66 | Ask: 5.67 Volume: 856,852 https://t.co/P3DBO4nFom
January 18th 2022, 9:01pm
phasefivebot @phasefivebot
$CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinica… https://t.co/UdOz6DbXBq
January 18th 2022, 9:01pm
semodough @semodough
$CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinica… https://t.co/0ljbiFJgGU
January 18th 2022, 9:01pm
FlashAlert_me @FlashAlert_me
$CMRX [15s. delayed]: Issued Press Release on January 18, 16:01:00: Chimerix Announces Publication of Positive ONC2… https://t.co/rxrnis1CSg
January 18th 2022, 9:01pm
StockTraderHub @StockTraderHub
$CMRX - Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research
January 18th 2022, 9:01pm
StockNewsBot2 @StockNewsBot2
$CMRX Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinica… https://t.co/58cPT7dmbZ
January 18th 2022, 9:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2022. All rights reserved.